Cited by 968Immune cells in cancerPhagocytosis and Immune RegulationCardiac Fibrosis and Remodeling

Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences

Stout, Robert D, Jiang, Chuancang, Matta, Bharati, Tietzel, Illya, Watkins, Stephanie K, Suttles, Jill·2005·The Journal of Immunology

Abstract

Recent studies have described the development of distinct functional subsets of macrophages in association with cancer, autoimmune disease, and chronic infections. Based on the ability of Th1 vs Th2 cytokines to promote opposing activities in macrophages, it has been proposed that macrophages develop into either type 1 inflammatory or type 2 anti-inflammatory subsets. As an alternative to the concept of subset development, we propose that macrophages, in response to changes in their tissue environment, can reversibly and progressively change the pattern of functions that they express. As demonstrated herein, macrophages can reversibly shift their functional phenotype through a multitude of patterns in response to changes in cytokine environment. Macrophages display distinct functional patterns after treatment with IFN-γ, IL-12, IL-4, or IL-10 and additional functional patterns are displayed depending on whether the cytokine is present alone or with other cytokines and whether the cytokines are added before or concomitantly with the activating stimulus (LPS). Sequential treatment of macrophages with multiple cytokines results in a progression through multiple functional phenotypes. This ability to adapt to changing cytokine environments has significant in vivo relevance, as evidenced by the demonstration that macrophage functional phenotypes established in vivo in aged or tumor-bearing mice can be altered by changing their microenvironment. A concept of functional adaptivity is proposed that has important implications for therapeutic targeting of macrophages in chronic diseases that result in the dominance of particular functional phenotypes of macrophages that play a significant role in disease pathology.

Integrity signals

Registry

Crossref · 10.4049/jimmunol.175.1.342

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Macrophages switch polarization states in response to their microenvironment.

    “Unlike terminally differentiated cells, macrophages switch polarization states in response to their microenvironment.This is emphasized by the contrasting gene expression during early and late stages of the FBR [24], as well as their ability to adapt functionality in response to the temporal presentation of stimuli [25].”
  • LPS-stimulated classically activated macrophages become TLR-tolerant and unable to produce similarly elevated pro-inflammatory cytokines upon second LPS exposure, but retain ability to produce anti-inflammatory cytokines like IL-10.

    “For example, in vitro experiments have shown that LPS stimulated, classically activated macrophages, become Toll-like receptor (TLR)-tolerant and unable to produce similarly elevated levels of pro-inflammatory cytokines upon second exposure to LPS [16–18].”
  • Macrophages have dynamic and plastic phenotypes that change with local microenvironmental signals, unlike lymphocytes whose phenotype is relatively fixed upon differentiation.

    “It has been shown that unlike lymphocytes, where cellular phenotype is relatively fixed upon differentiation, macrophages have dynamic and plastic phenotypes that change with local microenvironmental signals [5,14–16].”
  • A comprehensive in vivo macrophage phenotype cannot be deduced solely from a limited set of phenotypic markers.

    “Additionally, a comprehensive in vivo Mp phenotype cannot be deduced solely from a limited set of phenotypic markers, as different M2a-associated genes or proteins can exhibit entirely different temporal regulation and can be coexpressed with M1-associated markers [19,25,33,60,78].”

    From Macrophage phenotypes during tissue repair (2013) · cites this paper as [19]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., & Suttles, J.
Affiliations
University of Louisville (US)
Venue
The Journal of Immunology
Published
2005-07-01
Volume
175
Issue
1
Pages
342-349
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2121438383
Cited by
968
References
50
Citations by year
2026: 9 · 2025: 24 · 2024: 31 · 2023: 54 · 2022: 54 · 2021: 61 · 2020: 42 · 2019: 36 · 2018: 64 · 2017: 59 · 2016: 61 · 2015: 72 · 2014: 78 · 2013: 78 · 2012: 60
FWCI
8.32
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ag020972-04)
  • National Institute on Aging (R01 AG020972-02, AG20972, R01 AG020972-01A1)
  • National Institute of Allergy and Infectious Diseases (R01AI048850, AI48850)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Keywords
macrophage polarization, cytokine environment, Th1/Th2 cytokines, interferon-gamma, IL-12, IL-4, IL-10, lipopolysaccharide, tumor-bearing mice, aged mice, chronic disease, macrophage-targeted therapy
MeSH terms
Animals, Arginase, Environment, Female, Interferon-gamma, Ligands, Lipopolysaccharides, Macrophages, Mice, Inbred C57BL, Mice, Inbred DBA, Neoplasms, Experimental, Phenotype, Prostaglandin-Endoperoxide Synthases, Recombinant Proteins, Interleukin-4, Cytokines, Interleukin-10, Interleukin-12, Nitric Oxide Synthase, Mice, Cyclooxygenase 2, Nitric Oxide Synthase Type II

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review